...KRAS mutant Non-Small Cell Lung Cancer (NSCLC) cells, which may eventually overcome drug resistance associated with the ...
...KRAS oncogene, which is the most frequently mutated in human cancers. These compounds, along with their pharmaceutical c...
...KRAS reactivation. SOS1, a key guanine nucleotide exchange factor involved in KRAS activation and implicated in various ...
...KRAS mutation was statistically significantly associated with recurrence (p = 0.01). Transplant was performed a median o...
...KRAS mutations occurred in 29% of profiled patients, which was associated with reduced RFS (mutant vs. wild-type KRAS: m...
...Kras mutation induced ADM in pancreas. Metaplastic epithelial cells actively induced neuritogenesis, and neural remodeli...
...KRAS) mutations are poor prognostic factors in non-small cell lung cancer. We report two cases of metastatic KRAS G12C-p...
...KRAS-associated signaling pathways in the large duct type. Mutation analysis showed that KRAS and PIK3CA mutations were ...
...KRAS G12V mutation. During follow-up, she presented with vulvar, perineal, inguinal, and gluteal erythematous papules, n...
...KRAS G12D inhibitor MRTX1133 represents a major advance in targeting oncogenic KRAS, but adaptive resistance driven by E...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269